Registry of Lobbyists
Best Medicines Coalition / Coalition pour de meilleurs médicaments
| Subject matters | Details | Categories |
|---|---|---|
|
Health
|
Discuss Canada's response to the proposed bulk importation of medications from Canada to the United States.
|
Policies or Program, Regulation
|
|
Health
|
Ensure access to a comprehensive range of medicines and vaccines in Canada and protect access to clinical trials, while helping to rebuild domestic capacities to develop and make drugs and vaccines.
|
Policies or Program
|
|
Health
|
Ensure patient organizations are consulted and provide feedback on policies, processes, patient representation and other initiatives from Canada's Drug Agency.
|
Policies or Program
|
|
Health
|
Learn more about and provide feedback on plans around COVID-19 vaccines, including protein based ones.
|
Policies or Program
|
|
Health
|
Provide feedback on regulations to address health product shortages in Canada.
|
Regulation
|
|
Health
|
Provide input on a national strategy for drugs for rare diseases.
|
Policies or Program
|
|
Health
|
Provide input on pharmacare.
|
Policies or Program
|
|
Health
|
Provide input on proposed agile regulations and guidance for licensing drugs and medical devices.
|
Regulation
|
|
Health
|
Provide input on the modernization and development of preventive health care guidelines in Canada.
|
Policies or Program
|
|
Health
|
Recommend that the government and regulators adopt proactive approaches to communicating drug supply and shortages issues and measures to address them.
|
Regulation, Policies or Program
|
|
Health
|
Recommend that the government study and provide public interest funding so that the voices of patients, their needs and interests can be more adequately represented in public policy and regulatory matters.
|
Grant, Contribution or Other Financial Benefit, Policies or Program
|
|
Health
|
Recommend the creation of a Chief Patient Officer.
|
Policies or Program
|
|
Health
|
Recommend the creation of a Patient Ombudsman.
|
Policies or Program
|
|
Health
|
Share patient groups perspectives on drug pricing and access to medications/vaccines/clinical trials, specifically regulations and guidelines related to the Patented Medicine Prices Review Board, along with feedback on their policies and practices, and processes related to PMPRB.
|
Policies or Program, Regulation
|